Global NGS-based RNA-seq Market Survey and Trend Research 2018
Summary
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 NGS-based RNA-seq Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 NGS-BASED RNA-SEQ MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Illumina (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Thermo Fisher Scientific (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Pacific Biosciences of California (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 QIAGEN (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Oxford Nanopore Technologies (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Oxford Nanopore Technologies (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 PerkinElmer (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 GATC Biotech (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Agilent Technologies (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Roche (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Macrogen (Company Overview, Sales Data etc.)
4.12 Eurofins Scientific (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 NGS-based RNA-seq Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 NGS-BASED RNA-SEQ MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Illumina (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Thermo Fisher Scientific (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Pacific Biosciences of California (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 QIAGEN (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Oxford Nanopore Technologies (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Oxford Nanopore Technologies (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 PerkinElmer (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 GATC Biotech (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Agilent Technologies (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Roche (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Macrogen (Company Overview, Sales Data etc.)
4.12 Eurofins Scientific (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table Global NGS-based RNA-seq Market 2012-2017, by Type, in USD Million
Table Global NGS-based RNA-seq Market Forecast 2018-2023, by Type, in USD Million
Table Illumina Overview List
Table NGS-based RNA-seq Business Operation of Illumina (Sales Revenue, Cost, Gross Margin)
Table Thermo Fisher Scientific Overview List
Table NGS-based RNA-seq Business Operation of Thermo Fisher Scientific (Sales Revenue, Cost, Gross Margin)
Table Pacific Biosciences of California Overview List
Table NGS-based RNA-seq Business Operation of Pacific Biosciences of California (Sales Revenue, Cost, Gross Margin)
Table QIAGEN Overview List
Table NGS-based RNA-seq Business Operation of QIAGEN (Sales Revenue, Cost, Gross Margin)
Table Oxford Nanopore Technologies Overview List
Table NGS-based RNA-seq Business Operation of Oxford Nanopore Technologies (Sales Revenue, Cost, Gross Margin)
Table Oxford Nanopore Technologies Overview List
Table NGS-based RNA-seq Business Operation of Oxford Nanopore Technologies (Sales Revenue, Cost, Gross Margin)
Table PerkinElmer Overview List
Table NGS-based RNA-seq Business Operation of PerkinElmer (Sales Revenue, Cost, Gross Margin)
Table GATC Biotech Overview List
Table NGS-based RNA-seq Business Operation of GATC Biotech (Sales Revenue, Cost, Gross Margin)
Table Agilent Technologies Overview List
Table NGS-based RNA-seq Business Operation of Agilent Technologies (Sales Revenue, Cost, Gross Margin)
Table Roche Overview List
Table NGS-based RNA-seq Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
Table Macrogen Overview List
Table NGS-based RNA-seq Business Operation of Macrogen (Sales Revenue, Cost, Gross Margin)
Table Eurofins Scientific Overview List
Table NGS-based RNA-seq Business Operation of Eurofins Scientific (Sales Revenue, Cost, Gross Margin)
Table Global NGS-based RNA-seq Sales Revenue 2012-2017, by Companies, in USD Million
Table Global NGS-based RNA-seq Sales Revenue Share, by Companies, in USD Million
Table NGS-based RNA-seq Demand 2012-2017, by Application, in USD Million
Table NGS-based RNA-seq Demand Forecast 2018-2023, by Application, in USD Million
Table Global NGS-based RNA-seq Market 2012-2017, by Region, in USD Million
Table NGS-based RNA-seq Market Forecast 2018-2023, by Region, in USD Million
Table Global NGS-based RNA-seq Market 2012-2017, by Type, in USD Million
Table Global NGS-based RNA-seq Market Forecast 2018-2023, by Type, in USD Million
Table Illumina Overview List
Table NGS-based RNA-seq Business Operation of Illumina (Sales Revenue, Cost, Gross Margin)
Table Thermo Fisher Scientific Overview List
Table NGS-based RNA-seq Business Operation of Thermo Fisher Scientific (Sales Revenue, Cost, Gross Margin)
Table Pacific Biosciences of California Overview List
Table NGS-based RNA-seq Business Operation of Pacific Biosciences of California (Sales Revenue, Cost, Gross Margin)
Table QIAGEN Overview List
Table NGS-based RNA-seq Business Operation of QIAGEN (Sales Revenue, Cost, Gross Margin)
Table Oxford Nanopore Technologies Overview List
Table NGS-based RNA-seq Business Operation of Oxford Nanopore Technologies (Sales Revenue, Cost, Gross Margin)
Table Oxford Nanopore Technologies Overview List
Table NGS-based RNA-seq Business Operation of Oxford Nanopore Technologies (Sales Revenue, Cost, Gross Margin)
Table PerkinElmer Overview List
Table NGS-based RNA-seq Business Operation of PerkinElmer (Sales Revenue, Cost, Gross Margin)
Table GATC Biotech Overview List
Table NGS-based RNA-seq Business Operation of GATC Biotech (Sales Revenue, Cost, Gross Margin)
Table Agilent Technologies Overview List
Table NGS-based RNA-seq Business Operation of Agilent Technologies (Sales Revenue, Cost, Gross Margin)
Table Roche Overview List
Table NGS-based RNA-seq Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
Table Macrogen Overview List
Table NGS-based RNA-seq Business Operation of Macrogen (Sales Revenue, Cost, Gross Margin)
Table Eurofins Scientific Overview List
Table NGS-based RNA-seq Business Operation of Eurofins Scientific (Sales Revenue, Cost, Gross Margin)
Table Global NGS-based RNA-seq Sales Revenue 2012-2017, by Companies, in USD Million
Table Global NGS-based RNA-seq Sales Revenue Share, by Companies, in USD Million
Table NGS-based RNA-seq Demand 2012-2017, by Application, in USD Million
Table NGS-based RNA-seq Demand Forecast 2018-2023, by Application, in USD Million
Table Global NGS-based RNA-seq Market 2012-2017, by Region, in USD Million
Table NGS-based RNA-seq Market Forecast 2018-2023, by Region, in USD Million
LIST OF FIGURES
Figure NGS-based RNA-seq Industry Chain Structure
Figure Global NGS-based RNA-seq Market Growth 2012-2017, by Type, in USD Million
Figure Global NGS-based RNA-seq Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region
Figure NGS-based RNA-seq Industry Chain Structure
Figure Global NGS-based RNA-seq Market Growth 2012-2017, by Type, in USD Million
Figure Global NGS-based RNA-seq Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region
